Product Description
Growth Hormone Axis Research Peptide
Sermorelin is a laboratory-engineered fragment of
growth hormone–releasing hormone (GHRH 1–29) studied for its ability to stimulate
endogenous growth hormone (GH) secretion via pituitary signaling.
Originally utilized as a clinical probe of GH axis function, it is now widely explored in
non-clinical research models examining endocrine regulation and downstream physiological pathways.
Key Research Areas
🧬
Pituitary–GH axis signaling
and pulsatile growth hormone release models
🦴
Skeletal integrity and bone remodeling
research
🧠
Cognitive, neuroprotective, and neurologic
pathway investigations
❤️
Cardiac remodeling and tissue repair
studies
⚡
Performance, recovery, and endocrine adaptation
research models
This 5 mg presentation supports
controlled, repeatable laboratory study designs, making it suitable for extended investigations across
endocrine regulation and recovery-focused research pathways.
Intended Use
📦 Format: Lyophilized powder (5mg)
🧬 Compound: Sermorelin / GHRH 1–29
⚠️ Use: For laboratory research use only. Not for human or veterinary use.
Why Researchers Choose This Compound
🔗
Focused GHRH pathway relevance
supports precise research into endogenous GH signaling without multi-peptide complexity.
🧪
Broad endocrine and recovery utility
makes it useful for pituitary-axis, bone, tissue-repair, and performance-related pathway studies.
📈
Strong repeat-study value
offers a controlled framework for examining endocrine regulation and downstream physiologic pathway interaction.
Product Notes
✅ Research category: GH-axis and endocrine signaling
✅ Study context: Laboratory and non-clinical research models
✅ Compound focus: GHRH 1–29 activity, endogenous GH release, and downstream physiologic pathway regulation